Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bristol-Myers Squibb Co BMY

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSE:BMY)

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

GlobeNewswire 3 days ago

Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

PR Newswire 5 days ago

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Business Wire 8 days ago

Bristol Myers Squibb Reports First Quarter Financial Results for 2024

Business Wire 9 days ago

Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

Business Wire 12 days ago

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

Newsfile April 14, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

PR Newswire April 12, 2024

Building a Better Future: Bristol Myers Squibb 2023 ESG Report

Accesswire April 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

Accesswire April 10, 2024

Bullboard Posts (NYSE:BMY)

RE:RE:RE:RE:IVERMICTIN KILLS COVID 19 !

Microscopy Expert: Vials Contain Graphene Oxide, Parasites ... https://forbiddenknowledgetv.net/microscopy-expert...
zeropointenergy - October 16, 2021

RE:RE:RE:IVERMICTIN KILLS COVID 19 !

THE FAUCI INDICTMENT (Video) — SOTN: Alternative News ...   Oct 09, 2021 · THE FAUCI INDICTMENT…...
zeropointenergy - October 16, 2021

RE:RE:RE:IVERMICTIN KILLS COVID 19 !

IS THIS WHY PEOPLE ARE SICK OPP NEEDS TO INVESTIGATE!  Graphene in our foods, not just shots - ugetube.com https://ugetube...
zeropointenergy - October 10, 2021

RE:RE:IVERMICTIN KILLS COVID 19 !

BREAKING NEWS! SPANISH HIGH COURT CONFIRMS THAT … https://ugetube.com/watch/breaking-news-spanish-high-court-confirms... 2021...
zeropointenergy - October 10, 2021

RE:IVERMICTIN KILLS COVID 19 !

Dr. Richard Bartlett on Budesonide, the Silver Bullet ... https://www.thethinkingconservative.com/dr-richard...
zeropointenergy - October 9, 2021

IVERMICTIN KILLS COVID 19 !

 NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row  
zeropointenergy - October 9, 2021